Contact us

History
Viracell Company was founded in 2021 to develop and produce cell/gene therapy products and tissue engineering solutions.
The company’s product development plan is divided into three phases:
Short-term (first 2 years): Cell isolation kits
Medium-term (first 3 years): Tissue products and injectable cell-free therapy vials (containing growth factors secreted by cells) for topical treatment of hair loss, skin rejuvenation (dermatology), and osteoarthritis (orthopedics)
Long-term (first 5 years): Cell therapy for neurological diseases (Multiple Sclerosis and stroke) and cancer-related conditions (GvHD, colorectal cancer, and breast cancer)

Our mission
Creating innovative regenerative medicine solutions to become Iran’s most valuable company in the field — restoring life for patients, delivering value for customers, employees, investors, and partners.